Alzamend Neuro, Inc. (ALZN) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.74M | -1.17M | -2.36M | -688.71K | -1.42M | -3.4M | -1.06M | -1.43M | -2.03M | -1.51M | -3.3M | -2.24M |
| Operating CF Margin % | - | - | - | - | - | - | - | -1874.53% | - | - | - | - |
| Operating CF Growth % | -21.96% | 65.55% | -123.8% | 51.73% | 29.93% | -124.66% | 67.99% | 36.17% | -12.43% | 35.44% | -30.02% | -43.07% |
| Net Income | -2.2M | -1M | -2.7M | -1.14M | -985.78K | -1.42M | -974.41K | -851.53K | -2.66M | -2.91M | -3.53M | -3.31M |
| Depreciation & Amortization | 27.68K | 27.68K | 27.68K | 12.69K | 12.69K | 12.69K | 12.69K | 12.69K | 12.69K | 12.69K | 12.69K | 5.32K |
| Stock-Based Compensation | 9.3K | 31.51K | 42.9K | 81.28K | 81.28K | 81.28K | 81.28K | 81.28K | 186.64K | 318.34K | 369.38K | 491.33K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | -1.58M | 142.6K | 129.23K | -2.35M |
| Other Non-Cash Items | 695.02K | -229.88K | 0 | 0 | 0 | -2.26M | 9.29K | 107.36K | 1.58M | -142.6K | -129.23K | 2.35M |
| Working Capital Changes | -269.31K | 0 | 269.31K | 356.78K | -531.82K | 184.58K | -184.58K | -669.85K | 431.43K | 1.06M | -152.5K | 573.7K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.14M | -265.82K | 348.55K | 0 | 0 | 0 | 0 | 184.17K | 0 | 0 | -129.23K | 1.84M |
| Cash from Investing | 0 | 0 | 0 | -210K | 0 | 0 | -90K | 147.24K | 0 | 0 | -147.24K | 0 |
| Capital Expenditures | 0 | 0 | 0 | -210K | 0 | 90K | -90K | 147.24K | 0 | 0 | -147.24K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | 193.46% | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -90K | 0 | 0 | 0 | 0 | -147.24K | 0 |
| Cash from Financing | 0 | 0 | 4.04M | 1.49M | 688.7K | 6.3M | 1.96M | 1.52M | 2.11M | 18.09K | 0 | 200 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 688.7K | 1000K | 1000K | 0 | 964.45K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | -87.38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 600 | 87.38K | 1.17M | 0 | 1.52M | 1.15M | 18.09K | 0 | 200 |
| Net Change in Cash | -1.74M | -1.17M | 1.67M | 590.52K | -734.94K | 2.9M | 817.9K | 93.18K | 82.79K | -1.5M | -3.45M | -2.23M |
| Free Cash Flow | -1.74M | -1.17M | -2.36M | -898.71K | -1.42M | -3.31M | -1.15M | -1.28M | -2.03M | -1.51M | -3.45M | -2.24M |
| FCF Margin % | - | - | - | - | - | - | - | -1681.07% | - | - | - | - |
| FCF Growth % | -21.96% | 64.61% | -106.22% | 29.76% | 29.93% | -118.72% | 66.75% | 42.76% | -12.43% | 35.44% | -35.82% | -33.94% |
| FCF per Share | -0.46 | -0.35 | -1.12 | -1.26 | -2.32 | -8.44 | -13.43 | -16.73 | -25.92 | -20.75 | -47.25 | -31.18 |
| FCF Conversion (FCF/Net Income) | 0.79x | 1.17x | 0.87x | 0.60x | 1.37x | 2.50x | 1.08x | 1.68x | 0.76x | 0.52x | 0.93x | 0.68x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |